+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cell Therapy for Wound Healing Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 147 Pages
  • April 2025
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 6091759
The stem cell therapy for wound healing market is projected to grow at a CAGR of 22.06% over the forecast period, increasing from US$64.979 million in 2025 to US$176.061 million by 2030.

The stem cell therapy for wound healing market is witnessing significant growth, driven by technological advancements and the rising prevalence of chronic wounds. Increasing cases of diabetic ulcers, venous leg ulcers, and pressure ulcers are fueling the demand for innovative therapies that go beyond conventional treatments.

Stem cell research has introduced groundbreaking solutions that enhance wound healing by promoting tissue regeneration, angiogenesis, and inflammation modulation. Additionally, factors such as an aging population, a growing preference for minimally invasive treatments, and increased investments in regenerative medicine are further accelerating market expansion.

Market Trends:

  • Aging Population Driving Demand: The global rise in the aging population is a key factor fueling the growth of the stem cell therapy market for wound healing. Older adults are more prone to chronic conditions like diabetes, pressure ulcers, vascular diseases, and venous insufficiency, which lead to difficult-to-heal wounds. World Bank data indicates that the proportion of people aged 65 and older reached 10% in 2023, significantly increasing the need for advanced wound care solutions. Stem cell therapy provides a groundbreaking approach by leveraging stem cells' regenerative properties to promote tissue repair, enhance angiogenesis, and reduce inflammation.
  • Integration with Advanced Wound Care: Stem cell therapies are increasingly paired with next-generation wound care products, such as bioactive dressings and smart wound monitoring systems. This combination enhances healing outcomes through the synergistic action of regenerative stem cells and innovative wound management technologies.
  • North America Market Growth: In North America, the stem cell therapy market for wound healing is segmented into the United States, Canada, and Mexico. The U.S. market is experiencing rapid growth due to the rising prevalence of chronic wounds, including diabetic ulcers, pressure sores, and surgical wounds. Advances in techniques for isolating and expanding stem cells have improved their therapeutic efficacy, boosting confidence among healthcare providers in adopting stem cell therapies for wound healing.
Some of the major players covered in this report include Corning Inc., Schott AG, Swift Glass, Sydor Optics, Specialty Glass Products, AGC Inc., Precision Glass and Optics among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Global Stem Cell Therapy for Wound Healing Market Segmentation:

By Type

  • Mesenchymal Stem Cells (MSCs)
  • Embryonic Stem Cells (ESCs)
  • Induced Pluripotent Stem Cells (Ipscs)
  • Other Adult Stem Cell Types

By Application

  • Chronic Wounds
  • Diabetic Ulcers
  • Pressure Ulcers
  • Venous Ulcers
  • Acute Wounds
  • Burns
  • Surgical Wounds
  • Traumatic Wounds
  • Others

By End-User

  • Hospitals And Clinics
  • Home Healthcare
  • Others

By Region

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

Table of Contents

1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL ADVANCEMENTS
5. GLOBAL STEM CELL THERAPY FOR WOUND HEALING MARKET BY TYPE
5.1. Introduction
5.2. Mesenchymal Stem Cells (MSCs)
5.3. Embryonic Stem Cells (ESCs)
5.4. Induced Pluripotent Stem Cells (Ipscs)
5.5. Other Adult Stem Cell Types
6. GLOBAL STEM CELL THERAPY FOR WOUND HEALING MARKET BY APPLICATION
6.1. Introduction
6.2. Chronic Wounds
6.2.1. Diabetic Ulcers
6.2.2. Pressure Ulcers
6.2.3. Venous Ulcers
6.3. Acute Wounds
6.3.1. Burns
6.3.2. Surgical Wounds
6.3.3. Traumatic Wounds
6.4. Others
7. GLOBAL STEM CELL THERAPY FOR WOUND HEALING MARKET BY END-USER
7.1. Introduction
7.2. Hospitals And Clinics
7.3. Home Healthcare
7.4. Others
8. GLOBAL STEM CELL THERAPY FOR WOUND HEALING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Organogenesis Holdings Inc.
10.2. Smith & Nephew
10.3. Vericel Corporation
10.4. Mesoblast Limited
10.5. Cytori Therapeutics, Inc.
10.6. Tissue Regenix Group Plc
10.7. Athersys, Inc.
10.8. Stem Cell Care India
10.9. TruStem Cell Therapy
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations

Companies Mentioned

  • Organogenesis Holdings Inc.
  • Smith & Nephew
  • Vericel Corporation
  • Mesoblast Limited
  • Cytori Therapeutics, Inc.
  • Tissue Regenix Group Plc
  • Athersys, Inc.
  • Stem Cell Care India
  • TruStem Cell Therapy

Methodology

Loading
LOADING...

Table Information